AZTR vs BMY · $3.7M cap vs P/E 17, rev $24.46B
Azitra Inc (AZTR) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Azitra Inc (AZTR) is a biotechnology company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported AZTR revenue for 2025-12-31 was $0. Net income was -$11.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AZTR currently screens at market cap $3.7M.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
AZTR currently screens at market cap $3.7M. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the AZTR and BMY stock pages for the full models.
Not investment advice.